Statistical Considerations for Clinical Trials During COVID-19: Confirmatory Adaptive Platform Trial (CAPT) Design for COVID-19 Treatment (Part III)

Document Type

Article

Publication Date

5-11-2020

Publication Title

LinkedIn

Abstract

Part III of the article that describes confirmatory adaptive platform trial (CAPT) design for COVID-19 treatment development. We continue with the section on statistical methods for CAPT design, covering topics on sequential p-value and monitoring, point estimate and confidence interval, multiplicity in hypothesis testing, missing data handling, and use of non-concurrent controls. We finish the article with discussion on controversy of stochastic curtailment, inappropriateness of adaptive Bayesian design, and free software for group sequential designs.

Link to Full Text

Share

COinS